Vera Tiedje

737 total citations
24 papers, 511 citations indexed

About

Vera Tiedje is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Vera Tiedje has authored 24 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Vera Tiedje's work include Thyroid Cancer Diagnosis and Treatment (15 papers), Neuroendocrine Tumor Research Advances (6 papers) and BRCA gene mutations in cancer (4 papers). Vera Tiedje is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (15 papers), Neuroendocrine Tumor Research Advances (6 papers) and BRCA gene mutations in cancer (4 papers). Vera Tiedje collaborates with scholars based in Germany, United States and Austria. Vera Tiedje's co-authors include Dagmar Führer, James A. Fagin, Martin Stuschke, Kurt Werner Schmid, Frank Weber, Henning Dralle, Saskia Ting, Laura Moss, Lars C. Moeller and Denise Zwanziger and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Clinical Endocrinology & Metabolism and Nature Reviews Endocrinology.

In The Last Decade

Vera Tiedje

23 papers receiving 494 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Tiedje Germany 11 338 204 125 85 72 24 511
Vlasta Sýkorová Czechia 12 386 1.1× 143 0.7× 109 0.9× 129 1.5× 51 0.7× 18 501
Federica Panebianco United States 11 387 1.1× 183 0.9× 144 1.2× 138 1.6× 114 1.6× 16 593
Ann W. Gramza United States 10 206 0.6× 200 1.0× 137 1.1× 81 1.0× 181 2.5× 22 552
Alessia Tacito Italy 13 483 1.4× 184 0.9× 125 1.0× 149 1.8× 76 1.1× 20 608
Nicla Borrelli Italy 14 278 0.8× 147 0.7× 133 1.1× 54 0.6× 147 2.0× 24 548
Šárka Dvořáková Czechia 12 389 1.2× 141 0.7× 119 1.0× 127 1.5× 35 0.5× 21 527
José Cameselle-Teijeiro Spain 8 302 0.9× 103 0.5× 134 1.1× 74 0.9× 40 0.6× 9 405
Eliška Václavíková Czechia 14 492 1.5× 161 0.8× 143 1.1× 152 1.8× 55 0.8× 33 653
Karin Weijers Netherlands 7 226 0.7× 118 0.6× 72 0.6× 50 0.6× 47 0.7× 9 399
Fernando Rodrigues Portugal 11 279 0.8× 90 0.4× 112 0.9× 72 0.8× 32 0.4× 41 437

Countries citing papers authored by Vera Tiedje

Since Specialization
Citations

This map shows the geographic impact of Vera Tiedje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Tiedje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Tiedje more than expected).

Fields of papers citing papers by Vera Tiedje

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Tiedje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Tiedje. The network helps show where Vera Tiedje may publish in the future.

Co-authorship network of co-authors of Vera Tiedje

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Tiedje. A scholar is included among the top collaborators of Vera Tiedje based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Tiedje. Vera Tiedje is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krishnamoorthy, Gnana P., Anthony Glover, Brian R. Untch, et al.. (2025). RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs. The Journal of Experimental Medicine. 222(5). 1 indexed citations
2.
Brandenburg, Tim, Vera Tiedje, Sarah Theurer, et al.. (2025). Comprehensive Assessment of Multikinase Inhibitor Therapy Outcomes in RAIR-(P)DTC and MTC at a Tertiary Referral Center. The Journal of Clinical Endocrinology & Metabolism. 111(1). 167–179. 2 indexed citations
3.
4.
Brandenburg, Tim, Vera Tiedje, Sarah Theurer, et al.. (2021). Continued Discontinuation of TKI Treatment in Medullary Thyroid Carcinoma – Lessons From Individual Cases With Long-Term Follow-Up. Frontiers in Endocrinology. 12. 718418–718418. 6 indexed citations
5.
Saqcena, Mahesh, Luis J. Leandro‐García, Jesper L.V. Mååg, et al.. (2020). SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies. Cancer Discovery. 11(5). 1158–1175. 71 indexed citations
6.
Frank‐Raue, Karin, et al.. (2020). A Novel Double RET E768D/L790F Mutation Associated with a MEN2B-Like Phenotype. Thyroid. 31(2). 327–329. 3 indexed citations
7.
Tiedje, Vera & James A. Fagin. (2019). Therapeutic breakthroughs for metastatic thyroid cancer. Nature Reviews Endocrinology. 16(2). 77–78. 32 indexed citations
8.
Tiedje, Vera, Martin Stuschke, Frank Weber, et al.. (2018). Anaplastic thyroid carcinoma: review of treatment protocols. Endocrine Related Cancer. 25(3). R153–R161. 90 indexed citations
9.
Ting, Saskia, Vera Tiedje, Klaudia Brix, et al.. (2017). Differential regulation of monocarboxylate transporter 8 expression in thyroid cancer and hyperthyroidism. European Journal of Endocrinology. 177(3). 243–250. 19 indexed citations
10.
Tiedje, Vera, Saskia Ting, Thomas Herold, et al.. (2017). NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma. Oncotarget. 8(26). 42613–42620. 59 indexed citations
11.
Tiedje, Vera, et al.. (2016). Perspectives for immunotherapy in endocrine cancer. Endocrine Related Cancer. 23(10). R469–R484. 13 indexed citations
12.
Wendler, Julia, Matthias Kroiß, Michael C. Kreißl, et al.. (2016). Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in Germany. European Journal of Endocrinology. 175(6). 521–529. 80 indexed citations
13.
Tiedje, Vera, Katharina König, Saskia Ting, et al.. (2016). Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. Endocrine. 54(3). 733–741. 44 indexed citations
14.
Tiedje, Vera, Saskia Ting, Henning Dralle, Kurt Werner Schmid, & Dagmar Führer. (2015). Das medulläre Schilddrüsenkarzinom. Der Internist. 56(9). 1019–1031. 9 indexed citations
15.
Tiedje, Vera, Kurt Werner Schmid, Frank Weber, A. Bockisch, & Dagmar Führer. (2015). Differenzierte Schilddrüsenkarzinome. Der Internist. 56(2). 153–168. 8 indexed citations
16.
Tiedje, Vera, Saskia Ting, Tobias Herold, et al.. (2015). Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients. Experimental and Clinical Endocrinology & Diabetes. 122(3). 1 indexed citations
17.
Ting, Saskia, Vera Tiedje, Lars C. Moeller, et al.. (2014). MCT 8 and LAT 2 expression in differentially functioning benign and malignant thyroid tumors. Experimental and Clinical Endocrinology & Diabetes. 122(3). 1 indexed citations
18.
Raue, F., Martin Faßnacht, Dagmar Führer, et al.. (2014). Management des fortgeschrittenen medullären Schilddrüsenkarzinoms. Der Onkologe. 20(6). 591–598. 2 indexed citations
19.
Reitter-Pfoertner, Sylvia, Arndt von Haeseler, Raute Sunder‐Plaßmann, et al.. (2012). Identification of an ancient haemophilia A splice site mutation. Thrombosis Research. 130(3). 445–450. 6 indexed citations
20.
Tiedje, Vera, Daniela Dunkler, Cihan Ay, et al.. (2011). The role of fibrinogen plasma levels, the –455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis. Thrombosis and Haemostasis. 106(11). 908–913. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vlasta Sýkorová Breakdown of academic impact, for papers by Federica Panebianco Breakdown of academic impact, for papers by Ann W. Gramza Breakdown of academic impact, for papers by Alessia Tacito Breakdown of academic impact, for papers by Nicla Borrelli Breakdown of academic impact, for papers by Šárka Dvořáková Breakdown of academic impact, for papers by José Cameselle-Teijeiro Breakdown of academic impact, for papers by Eliška Václavíková Breakdown of academic impact, for papers by Karin Weijers Breakdown of academic impact, for papers by Fernando Rodrigues
Rankless by CCL
2026